WallStSmart

DaVita HealthCare Partners Inc (DVA)vsNewmont Goldcorp Corp (NEM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Newmont Goldcorp Corp generates 66% more annual revenue ($22.67B vs $13.64B). NEM leads profitability with a 31.2% profit margin vs 5.5%. DVA appears more attractively valued with a PEG of 0.56. DVA earns a higher WallStSmart Score of 66/100 (B-).

DVA

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 8.7Quality: 4.3
Piotroski: 3/9Altman Z: 1.22

NEM

Strong Buy

65

out of 100

Grade: B-

Growth: 6.7Profit: 9.0Value: 4.7Quality: 8.0
Piotroski: 6/9Altman Z: 2.04
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DVAUndervalued (+11.7%)

Margin of Safety

+11.7%

Fair Value

$163.40

Current Price

$155.11

$8.29 discount

UndervaluedFair: $163.40Overvalued
NEMSignificantly Overvalued (-184.1%)

Margin of Safety

-184.1%

Fair Value

$43.86

Current Price

$101.52

$57.66 premium

UndervaluedFair: $43.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DVA3 strengths · Avg: 8.7/10
Return on EquityProfitability
64.8%10/10

Every $100 of equity generates 65 in profit

PEG RatioValuation
0.568/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

NEM6 strengths · Avg: 9.3/10
Profit MarginProfitability
31.2%10/10

Keeps 31 of every $100 in revenue as profit

Operating MarginProfitability
58.1%10/10

Strong operational efficiency at 58.1%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Market CapQuality
$108.06B9/10

Large-cap with strong market position

Return on EquityProfitability
22.3%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Areas to Watch

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

NEM2 concerns · Avg: 2.0/10
PEG RatioValuation
2.782/10

Expensive relative to growth rate

EPS GrowthGrowth
-4.6%2/10

Earnings declined 4.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : DVA

The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.

Bull Case : NEM

The strongest argument for NEM centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 31.2% and operating margin at 58.1%. Revenue growth of 20.6% demonstrates continued momentum.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Bear Case : NEM

The primary concerns for NEM are PEG Ratio, EPS Growth.

Key Dynamics to Monitor

DVA profiles as a value stock while NEM is a growth play — different risk/reward profiles.

DVA carries more volatility with a beta of 0.93 — expect wider price swings.

NEM is growing revenue faster at 20.6% — sustainability is the question.

NEM generates stronger free cash flow (1.4B), providing more financial flexibility.

Bottom Line

DVA scores higher overall (66/100 vs 65/100). Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Newmont Goldcorp Corp

BASIC MATERIALS · GOLD · USA

Newmont Corporation, based in Greenwood Village, Colorado, United States, is one of the largest gold mining companies in the world.

Visit Website →

Want to dig deeper into these stocks?